Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

Anders Granholm, Maj-Brit N. Kjær, Marie Warrer Munch, Sheila Nainan Myatra, Bharath Kumar Tirupakuzhi Vijayaraghavan, Maria Cronhjort, Rebecka Rubenson Wahlin, Stephan M. Jakob, Luca Cioccari, Gitte Kingo Vesterlund, Tine Sylvest Meyhoff, Marie Helleberg, Morten Hylander Møller, Thomas Benfield, Balasubramanian Venkatesh, Naomi Hammond, Sharon Micallef, Abhinav Bassi, Oommen John, Vivekanand Jha, Klaus Tjelle Kristiansen, Charlotte Suppli Ulrik, Vibeke Lind Jørgensen, Margit Smitt, Morten H. Bestle, Anne Sofie Andreasen, Lone Musaeus Poulsen, Bodil Steen Rasmussen, Anne Craveiro Brøchner, Thomas Strøm, Anders Møller, Mohd Saif Khan, Ajay Padmanaban, Jigeeshu Vasishtha Divatia, Sanjith Saseedharan, Kapil Borawake, Farhad Kapadia, Subhal Dixit, Rajesh Chawla, Urvi Shukla, Pravin Amin, Michelle S. Chew, Christian Wamberg, Neeta Bose, Mehul Shah, Iben Strøm Darfelt, Christian Gluud, Theis Lange, Anders Perner

2022Intensive Care Medicine31 citationsDOI Open Access PDF

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)AnesthesiologyDexamethasonePain medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Term (time)Intensive care medicineIntensive careEmergency medicineAnesthesiaInternal medicineVirologyOutbreakDiseaseQuantum mechanicsPhysicsInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Adrenal Hormones and Disorders